DENISE HECHT-HEWIT: Open Payments
NPI 1366708976 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 32 payments from 11 companies in 2025. Trend: 2023 $765 · 2024 $968 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $204 |
| Neurocrine BioSciences, Inc. | 5 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| ABBVIE INC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Tris Pharma Inc | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: HETLIOZ, INGREZZA, CAPLYTA, VRAYLAR, REXULTI, COBENFY, ABILIFY MAINTENA, INVEGA.
Industry payments across OH — which companies pay providers there.
